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SUMMARY. Objective. The status of carbohydrate metabolism of pregnant women with positive glucose challenge test
(GCT), but normal oral glucose tolerance test (OGTT) and their neonates are not defined clearly. Study Design. Pregnant
women with normal GCT (n: 120), with abnormal glucose challenge test (AGCT) but normal OGTT (n: 67) and with ges-
tational diabetes (GDM, n: 67) were included into the study. Insulin sensitivity was evaluated by fasting insulin level, ho-
meostasis model assessment of insulin resistance index (HOMA-IR); quantitative insulin check index (QUICKI) and
IS
OGTT
. Serum insulin and glucose values during OGTT were documented. Perinatal outcome and delivery modalities
were compared. Results. Both GDM (31.6±5.9 yrs) and AGCT groups (29.0±4.0 yrs) were older than controls (28.1±4.9
yrs). Body mass index (BMI) was the predominant factor affecting both AGCT and GDM groups (OR: 3.78 and 5.97 re-
spectively). Despite there was no significance between insulin indices; serum glucose and insulin values were similarly
different; macrosomic infant and caesarean section rates were higher than controls in both GDM and AGCT groups in fa-
vor of gestational diabetics (6.6% vs. 18.9%; p=0.0001 and 20% vs. 27.7% p=0.0001 respectively). Conclusion. Preg-
nant woman with abnormal glucose challenge test have impaired carbohydrate metabolism as in gestational diabetics
with a lesser severe degree.
Izvorni ~lanak
Klju~ne rije~i: 50 g test probira glukozom, test optere}enja glukozom, blagi gestacijski dijabetes, gestacijski dijabetes,
razina inzulina, trudno}a
SA@ETAK. Cilj istra`ivanja. Stanje metabolizma ugljikohidrata u trudnica s pozitivnim testom probira (glucose challen-
ge test – GCT), a normalnim testom optere}enja glukozom (OGTT) te njihove novoro|en~adi, nije jasno definirano.
Na~in istra`ivanja. U studiju su uklju~ene trudnice s normalnim GCT-om (n: 120), s abnormalnim GCT-om ali normal-
nim OGTT-om (n:67 te trudnice s gestacijskim dijabetesom (n: 67). Insulinska osjetljivost je vrednovana jutarnjiom vri-
jedno{}u insulina, modelom prosudbe homeostaze indeksom rezistencije na inzulin (HOMA-IR), kvantitativnim indek-
som provjere insulina (QUICKI) i IS
OGTT
-om. Vrijednosti serumske glukoze i inzulina su analizirane. Uspore|en je peri-
natalni ishod i na~in poroda. Rezultati. Trudnice s GDM (31,6±5,9 godina) i one s AGCT (29,0±4,0 godina) su bile starije
dobi od kontrolnih trudnica (28,1±4,9 godina). Indeks tjelesne te`ine (BMI) je bio presudni ~imbenik u skupini s AGCT i
GDM (OR: 3,78 odnosno 5,97). Unato~ tome nije bilo zna~ajnosti me|u inzuilinskim indeksima; serumske vrijednosti
glukoze i inzulina su bile sli~no razli~ite; makrosomna djeca i stopa carskih rezova su u trudnica s AGCT i OGTT bile
~e{}e, posebice u trudnica s GDM (6,6% prama 18,9%, p = 0,0001; 20% prama 27,7%, p = 0,0001). Zaklju~ak. Trudnice
s abnormalnim testom probira na glukozu (AGCT) imaju poreme}aj metabolizma ugljikohidrata kao i trudnice s gestacij-
skim dijabetesom (GDM), ali u ne{to manjoj mjeri.
Introduction
It is well documented that the pregnancy is the insulin
resistant state which can be tolerated by most of the
women with normal glucose metabolism. However,
some pregnant women experience carbohydrate intoler-
ance with various degrees during their pregnancies. Al-
though the certain mechanism of this pregnancy de-
pendent carbohydrate intolerance has not been well
known yet, excessive insulin resistance, which means
reduced insulin response to carbohydrates or low insulin
sensitivity and beta cell dysfunction are the common
characteristics of the subjects. Diagnostic methods of
this heterogeneous group of pregnant women are also
under debate. Gestational diabetes mellitus (GDM) af-
fects the 1 to 14 percent of the pregnancies according to
the diagnostic test which was preformed by their physi-
cian.
1,2
Today, one-step and two-step approaches are the
common tests for the detection of gestational diabetes.
3
The 50-g, 1-hour oral glucose challenge test (GCT), fol-
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lowed by 100-g, 3-hour oral glucose tolerance test
(OGTT) as the two-step approach, has gained wide-
spread acceptance as a universal screening tool for
GDM.
4
At present, the status of carbohydrate metabo-
lism of pregnant women with high glucose levels, which
exceeds the critical threshold value of GCT, but normal
100-g, 3-hour OGTT have not been evaluated clearly
yet. In few studies the group of pregnants with positive






Also some other studies focused on
minor degrees of glucose intolerance which is not well
defined with either »National Diabetes Data Group« or
Carpenter and Coustan’s criteria. Despite the increment
of perinatal adverse outcomes were pointed out in these
studies, a common treatment strategy to this group of
pregnant women has not been defined yet. Current ap-
proach is to leave them untreated unless their blood glu-
cose levels exceed defined cut-off values. The ideal
threshold value for the GCT has also not been identified
yet. Sensitivity of the test totally depends on the thresh-
old value. Detection rate of GDM will be 99% and 80%
with serum glucose values of 135 mg/dL and 140 mg/dL
respectively.
8
In any case maternal and fetal, long and
short-term adverse effects are the major concern for the
early detection and the treatment of carbohydrate intol-
erance in pregnancy.
9,10
Some mathematical relations between fasting insulin
and glucose values are widely used to simplify the eval-
uation of the abnormality of carbohydrate metabolism
during pregnancy. Homeostasis model of assessment of
insulin resistance index (HOMA-IR) and quantitative
insulin sensitivity check index (QUICKI) are simple and
widely used formulations to evaluate the insulin resis-
tance/sensitivity in pregnancy. Also IS
OGTT
has been re-
ported to estimate insulin sensitivity in pregnancy better
than fasting glucose and insulin values.
11–13
The aim of this study is to evaluate the carbohydrate
intolerance and fetal outcomes in pregnant subjects with
abnormal GCT and normal OGTT in Turkish popula-
tion; by using insulin indexes and the insulin and glu-
cose values during OGTT.
Materials and methods
This clinical trial was conducted at the Obstetrics and
Gynecology Department at Inonu University between
January 2005 and January 2006. The study was ap-
proved by the local ethical committee and the written in-
formed consent was obtained from each subject.
Study subjects
Two hundred fifty-four pregnant subjects were se-
lected from 441 pregnant women attended to the outpa-
tient clinic between 24 and 28 weeks of gestation. The
study population consisted of Turkish women living in
Eastern Region of Turkey. Singleton and uncomplicated
pregnancies with body mass index <30 kg/m
2
were in-
cluded into the study. The control group was randomly
selected from pregnant women with normal glucose
challenge test. Gestational age was based on last men-
strual period and according to a reliable menstrual his-
tory confirmed by ultrasonography before 20 weeks of
gestation.
All the pregnant women underwent 50-g glucose
challenge test as our routine antenatal screening proto-
col. Fifty grams of glucose was administered orally re-
gardless of the time of the day or the fasting state. Ve-
nous plasma glucose was measured at the first hour of
the glucose load. A value of plasma glucose 140 mg/dL
(7.8 mmol/L) was accepted as the threshold value for the
positive glucose challenge test. Pregnant women with a
positive challenge test underwent 3-hour 100-g OGTT
within 7 days.
11
According to Carpenter and Coustan
criteria
10
at least two plasma glucose levels exceeding
the cut-off values following OGTT were essential for
the diagnosis of GDM. Women with one abnormal
value were excluded from the study.
The subjects were classified into 3 groups according
to the OGTT and GCT results: group 1 (n: 120) pregnant
women with normal GCT served as control group;
group 2 (n: 67) women with abnormal glucose challenge
test (AGCT), and group 3 (n: 67) gestational diabetics.
Blood samples were collected at 8:00 am after 12-hours
fast and at 60, 120 and 180 minutes following the 100-g
oral glucose load. Plasma glucose levels were measured
by hexokinase method using Olympus autoanalyser
(Olympus Diagnostica GmbH-Irish Branch-Lismeehan)
and plasma insulin levels were measured by chemil-
uminescent enzyme immunoassay method using Immu-
lite 2000 autoanalyser (Diagnostic Products Corpora-
tion, Los Angeles, CA, USA).
The insulin sensitivity index from the OGTT was cal-
culated according to 3 mathematical equations. First
equation was HOMA-IR which was derived from the
product of fasting plasma glucose HOMA-IR = (FPG ×
FPI)/22.5 mmol/L and fasting plasma insulin (FPI
µU/L) divided by a constant.
12
The second equation was
QUICKI which was the inverse log sum of fasting insu-
lin (I
0
) and fasting glucose (G
o





). The third equation was IS
OGTT
in which
insulin sensitivity is estimated by dividing a constant
(10.000) by the square root of the product of fasting
plasma glucose (FPG) times fasting plasma insulin
(FPI) times the mean glucose (G) times mean insulin (I)
IS
OGTT
=10.000/ (FPG × FPI) × (G × I).
13
Body mass index (BMI) was calculated as the ratio
between weight (kg) and height (m
2
).
Subjects in Group 2 and 3 had diet or diet and insulin
therapy as indicated. Daily caloric intake was arranged
by a registered dietitian according to the pregestational
BMI varying between 25–35 kcal per kg per day of ac-
tual weight; as 3 meal and 4 snacks.
14
Insulin therapy
with short acting insulin lispro as intensive insulin ther-
apy (3 premeal doses lispro and 1 bedtime NPH insulin)
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has been started when the capillary blood glucose levels
exceed 95 mg/dl (5.3 mmol/L) in the fasting state or 120
mg/dl (6.7 mmol/L) 2 hours after meal despite dietary
recommendations.
15–16
All study subjects were educated for nutrition, exer-
cise, capillary blood glucose monitorisation and hypo-
glycemia by a team including an obstetrician, an endo-
crinologist, a dietitian and a nurse. Pregnant women
treated with insulin and diet therapy were followed up
by home blood glucose monitoring system using re-
flectancemeter. The goal of the therapy was maintaining
capillary blood fasting glucose levels 95 mg/dl, 2-hour
values 120 mg/dl and during the night 60 mg/dl (3.3
mmol/L) with an average 100 mg/dl (5.5 mmol/L) (14).
Fetal well-being was monitored by clinical assess-
ment and non-stress CTG test (NST) and detailed ultra-
sound scan for estimated fetal weight, polyhydramnios
and other anomalies. Beginning from 28 weeks of gesta-
tion all study subjects had NSTs and ultrasonographic
examination every 2 weeks until 40 weeks of gestation
unless there has been any abnormality. Patients either
with AGCT or GDM treated with diet were followed un-
til 40 weeks of gestation. If there was associated ma-
crosomia and a history of previous cesarean section,
elective cesarean section was planned. Cesarean section
rate, stillbirth, perineal lacerations and pre-eclampsia,
were considered as maternal adverse outcomes.
Intrapartum electronic fetal monitoring was done for
all pregnant women during labor. Birth weight, 5-min-
ute Apgar score, umbilical artery pH values and base ex-
cess, hypoglycemia, neonatal intensive care unit stay
(NICU) were recorded for all newborns. Macrosomia
was defined as a birth weight exceeding or equal to 4000
grams. Fetal hypoxia was assessed as umbilical artery
pH value 7.10 and base deficit –12. Neonatal hypo-
glycemia was diagnosed if any of two consecutive blood




Statistical analyses were performed by SPSS
®
for
Windows version 13.0 (Chicago, IL, USA). Data are ex-
pressed as means ± SD (standard deviation). Normality
for continued variables in groups was determined by the
Shapiro Wilk test. The ANOVA was used to compare
parametric data and Least significant difference (LSD)
test was used for comparison of variables. Pearson
chi-squared test was used for the evaluation of categori-
cal data; i.e. age, history, pregestational BMIs. Fisher’s
exact test was used for comparison of fasting glucose
values of the groups. A p value of less than 0.05 was
considered significant. To quantify the prediction of de-
veloping both AGCT and GDM based on patients char-
acteristics, logistic regressions were performed to select
the significant factors when the characteristics were
considered jointly.
Results
Demographic characteristics of the pregnant women
were given on Table 1. The pregnants in both AGCT and
GDM groups were similarly older than control subjects.
Both pregestational and in the course of GCT, BMIs were
higher in AGCT and GDM groups compared to controls;
GDM group was more obese than AGCT group. The
groups were matched for parity and diabetic family his-
tory: the history of gestational diabetes in previous preg-
nancies was significantly higher in GDM group.
The baseline metabolic charactheristics of the three
groups were documented on Table 2. In both AGCT and
GDM groups GCT insulin values were significantly and
similarly higher than control subjects. There was no sig-
nificant difference for fasting insulin, HOMA-IR,
QUICKI and IS
OGTT
values between groups; but fasting
glucose values were higher in both AGCT and GDM
groups compared to controls in favor of GDM group
(p=0.0001).
Table 1. Maternal and neonatal characteristics of control, AGCT and GDM groups
Tablica 1. Maj~inske i novoro|ena~ke karakteristike kontrolne, AGCT i GDM skupine
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3330.0±524.5




GCT BMI: Body mass index during glucose challenge test
* AGCT vs. control p=0.02;
†
GDM vs. control p=0.001;
‡





GDM vs. control p= 0.04;
$
GDM vs. AGCT p=0.001;
#
AGCT vs. control p= 0.001
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After adjustment for maternal age (25 years), pre-
pregnancy BMI, family history for diabetes and fasting
glucose values, pre-pregnancy BMI was the common
and most predictive factor for the development of both
AGCT and GDM (p=0.0001 for both). The odds ratios
(OR) and confidence intervals (CI) of the parameters are
documented on Table 3.
Blood glucose and insulin values of OGTT were
shown in Figure 1 and Figure 2. Glucose levels in whole
OGTT intervals were significantly higher in GDM
group compared to both AGCT, and control groups but
only the 60 minute value was significantly higher in
AGCT group compared to the controls. The insulin lev-
els were similarly high in both GDM and AGCT groups
compared to controls in all time intervals. Additionally,
except for 60-minute value, insulin levels were signifi-
cantly higher in GDM group compared to AGCT group.
The rate of macrosomia was significantly higher in
both AGCT and GDM groups compared to controls in
favor of GDM group (6.6% vs. 18.9%; p=0.0001). In ad-
dition, the rate of caesarean section due to macrosomia
was significantly higher in both AGCT and GDM
groups compared to controls; in favor of GDM group
(20% vs. 27.7%; p=0.0001 respectively). One of the pa-
tients in GDM group experienced severe preeclampsia.
The complications of neonatal hypoglycemia, low
Apgar score (5 min <7), low umbilical artery pH (7.10)
and base excess (12) and NICU stay were all seen in
the unique neonate of these mothers. The neonates were
comparable for gestational age at birth; and mean birth
weight for all the three groups (Table 1).
As reflecting the increment of insulin resistance with
advanced age and increased body fat mass, maternal age
was significantly and positively correlated with fasting
Table 2. The baseline metabolic parameters of control, AGCT, and GDM
groups
Tablica 2. Temeljni metaboli~ki pokazatelji kontrolne, AGCT i GDM
skupine






































































All the parameters are presented as median followed by interquartile
ranges in parentheses. GCT: glucose challenge test.
* GDM vs. AGCT p=0.0001;
†




Table 3. The predictive factors for AGCT and GDM
Tablica 3. Pretkazativni ~imbenici za AGCT i GDM
Odds ratio (95% CI) p value
AGCT Group
Age (25 yrs)
























Figure 1. Line graphics of glucose levels during a 3 hour 100 g OGTT in
control, AGCT and GDM groups
Slika 1. Grafikon razine glukoze tijekom 3-satnog 100 g OGTT-a u
kontrolnoj, AGCT i GDM skupini
Figure 2. Line graphics of insulin levels during a 3 hour 100 g OGTT in
control, AGCT and GDM groups
Slika 2. Grafikon razine inzulina tijekom 3-satnog 100 g OGTT-a u
kontrolnoj, AGCT i GDM skupini
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glucose, HOMA-IR, glucose and insulin values during
the course of GCT. Pregestational BMI was also posi-
tively correlated with fasting glucose-insulin; and glu-
cose-insulin concentrations during the course of GCT;
and negatively correlated with QUICKI. The correlation
coefficients and p values are documented on Table 4.
Discussion
To our knowledge, this is one of the first prospective
clinical trials evaluating the charactheristics of the car-
bohydrate metabolism in pregnant women with abnor-
mal glucose challenge test, but normal 100-g 3-hour
OGTT in Turkish population.
The close relationship between impaired carbohy-
drate metabolism and increased age and BMI are re-
ported by several authors.
18–20
In our study fasting glu-
cose, glucose-insulin levels of GCT, and HOMA-IR
values were found to be strongly and positively corre-
lated with age. Additionally in both of our GDM and
AGCT groups the patients were older than control sub-
jects, as supporting the hypothesis that advanced age
detoriates the carbohydrate metabolism.
7
Also, age over
25 years was one of the affecting factors for develop-
ment of AGCT (odds ratio 3.12).
Although our study groups were consisted of women
with BMI<30 kg/m
2
– to exclude the effect of obesity-
the severity of carbohydrate intolerance was found to be
increased correlated with BMI. Furthermore BMI was
the common and significant predictive factor for devel-
opment of both AGCT and GDM (odds ratios were 3.78
and 5.97 respectively). Normal pregnancy is accompa-
nied by an ascending insulin resistance that increases as
gestation proceeds. It can be concluded that, on the basis
of this physiology, the increased BMI has an additive
and worsening effect on the process. but not enough to
predict the subsequent AGCT or GDM during the cur-
rent pregnancy.
As supporting the previous data,
21
parity was found to
be insignificant as an predictive factor for both subse-
quent AGCT and GDM in our study groups.
Chronic insulin resistance in GDM has been docu-
mented by various studies.
3,22,23
Also, a compensatory
pancreatic insulin production leading to a state of hy-
perinsulinemia which is an essential event preceding the
development of GDM during pregnancy has been well
documented. In the present study fasting glucose values
were significantly higher in both AGCT and GDM
groups compared to controls, while the fasting insulin
levels were similar in all 3 groups. Additionally GCT in-
sulin and glucose values were similarly high in both
AGCT and GDM groups compared to control group.
Significant increments have been detected in insulin
levels at the second hour of glucose load during OGTT
both in AGCT and GDM groups. Putting together, our
data supports the hypothesis of increased tissue resis-
tance to insulin secretion together with reduced early in-
sulin response in the pathogenesis of glucose intoler-
ance in AGCT group similar but in lesser degree to
GDM.
24,25
We have measured three indices to evaluate insulin
resistance and insulin sensitivity in our study subjects.
HOMA-IR model was the first index that we used to
evaluate insulin resistance based on liver and pancreatic
-cell interactions related to plasma glucose and insulin
levels. Although HOMA-IR has some limitations to re-
flect the peripheral insulin sensitivity, it was proven to
be a good predictor of the total insulin sensitivity.
26
We
used QUICKI as the second index to measure insulin
sensitivity, which is preferred in clinical trials, since sin-
gle blood sample is enough for the mathematical calcu-
lation.
14
We also calculated IS
OGTT
to asses and compare
the peripheral insulin sensitivity. IS
OGTT
is considered
more informative index for prediction of peripheral in-
sulin sensitivity, since it reflects the insulin-mediated
glucose uptake after glucose load.
14
However none of
these indexes were statistically different between our
study groups. As reflecting the increased insulin resis-
tance, insulin levels were found to accelerate during
OGTT but not in fasting state; this could be the possible
result of insignificant indexes; HOMA-IR and QUICKI
which root from fasting values. Despite showing no sta-
tistical significance IS
OGTT
values were found to decrease
parallel to severity of carbohydrate intolerance.
11–13,25,26
According to our follow up protocol we treated our
patients no matter with AGCT or GDM, until achieving
the goals for defined glucose values:
14
either with diet or
if needed with insulin. However the macrosomic infant
rates were significantly higher in both of the groups
compared to controls with a higher rate in GDM group.
The caesarian section rates due to macrosomia were
similarly high in both AGCT and GDM groups. But the
subjects could be preserved from other well known
Table 4. The correlating parameters with age and prepregnancy BMI
Tablica 4. Usporedbeni pokazatelji dobi i BMI prije trudno}e






























GCT: Glucose challenge test
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complications. There was no difference for gestational
age at birth and mean birth weight of the newborns.
Tight diet and insulin therapy prevented the maternal
and neonatal adverse outcomes except macrosomia in
AGCT and GDM groups.
The limitation of this study is the lack of an untreated
AGCT group i.e. of comparing their outcomes with nor-
mal pregnant women. But for avoiding both maternal
and fetal complications, we could not consist such an
untreated group ethically.
In conclusion, data obtained from this Turkish preg-
nant women based study, demonstrate that pregnant
women with abnormal glucose challenge test have im-
paired carbohydrate metabolism as in gestational diabet-
ics. Decreased insulin sensitivity and increased insulin
resistance in AGCT group is similar with the gestational
diabetics, with a less severity. So, it would be appreciable
to these pregnants to be followed up and treated as gesta-
tional diabetics. Comparable results with new studies will
allow us to define and treat the pregnant women with
abnormal glucose challenge test thoroughly.
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